Perinatal exposure to diethyl-hexyl-phthalate induces obesity in mice

Frontiers in Bioscience - Elite

Volumn 5 E, Issue 2, 2013, Pages 725-733

  Hao, Chanjuan ^a,b   Cheng, Xuejia ^a,b   Guo, Jian ^c   Xia, Hongfei ^a,b   Ma, Xu ^a,b  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^c National Quality Supervision and Test Center for Grain and Oil   (China)

Author keywords

Adipogenesis; Diethyl hexyl phthalate; Obesity; Perinatal exposure; Peroxisome proliferator activated receptor gamma

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CHOLESTEROL; GLUCOSE; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; AZO COMPOUND; OIL RED O; PRIMER DNA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CELL DIFFERENTIATION; CELL STRAIN 3T3; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EMBRYO; ENVIRONMENTAL EXPOSURE; EPIDIDYMIS FAT; FEMALE; GENE TARGETING; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; LIPID BLOOD LEVEL; LIPID STORAGE; MALE; MOUSE; NONHUMAN; OBESITY; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION;

MURINAE; MUS;

3T3-L1 CELLS; ADIPOCYTES; ANALYSIS OF VARIANCE; ANIMALS; AZO COMPOUNDS; CELL DIFFERENTIATION; DIETHYLHEXYL PHTHALATE; DNA PRIMERS; FEMALE; MALE; MICE; MICE, INBRED C57BL; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REAL-TIME POLYMERASE CHAIN REACTION;

MLCS; MLOWN;

EID: 84878510636     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e653     Document Type: Article

References (37)

1. Collins S.: Overview of clinical perspectives and mechanisms of obesity. Birth Defects Res A Clin Mol Teratol 73, 470-471 (2005)
2. Mokdad, A.H., E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, V.S. Bales, J.S. Marks: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76-79 (2003)
3. Mokdad, A.H., M.K. Serdula, W.H. Dietz, B.A. Bowman, J.S. Marks, J.P. Koplan: The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282, 1519-1522 (1999)
4. Ogden, C.L., K.M. Flegal, M.D. Carroll, C.L. Johnson: Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288, 1728-1732 (2002)
5. Desvergne B., J.N. Feige, C. Casals-Casas: PPAR-mediated activity of phthalates: A link to the obesity epidemic? Mol Cell Endocrinol 304, 43-48 (2009)
6. Goncharov, A., R.F. Haase, A. Santiago-Rivera, G. Morse, Akwesasne Task Force on the Environment, R.J. McCaffrey, R. Rej, D.O. Carpenter: High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a Native American population. Environ Res 106, 226-239 (2008)
7. Gladen B.C., N.B. Ragan, W.J. Rogan: Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr 136, 490-496 (2000)
8. Vasiliu O., L. Camero, J. Gardiner, P. Deguire, W. Karmaus: Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 17, 352-359 (2006)
9. Lee, D.H., I.K. Lee, S.H. Jin, M. Steffes, D.R. Jr. Jacobs: Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 30, 622-628 (2007)
10. Lee D.H., M.W. Steffes, D.R. Jr. Jacobs: Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes? Diabetologia 51, 402-407 (2008)
11. Pelletier, C., E. Doucet, P. Imbeault, A. Tremblay: Associations between weight loss-induced changes in plasma organochlorine concentrations, serum T(3) concentration, and resting metabolic rate. Toxicol. Sci 67, 46-51 (2002)
12. Smink, A., N. Ribas-Fito, R. Garcia, M. Torrent, M.A. Mendez, J.O. Grimalt, J. Sunyer: Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr 97, 1465-1469 (2008)
13. Stahlhut, R.W., E. van Wijngaarden, T.D. Dye, S. Cook, S.H. Swan: Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ. Health Perspect 115, 876-882 (2007)
14. Hatch, E.E., J.W. Nelson, M.M. Qureshi, J. Weinberg, L.L. Moore, M. Singer, T.F. Webster: Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 7, 27 (2008)
15. Takeuchi, T., O. Tsutsumi, Y. Ikezuki, Y. Takai, Taketani, Y: Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 51, 165-169 (2004)
16. Grün F., B. Blumberg: Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147, S50-55 (2006)
17. Baillie-Hamilton, P.F.: Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 8, 185-192 (2002)
18. Heindel, J.J.: Endocrine disruptors and the obesity epidemic. Toxicol Sci 76, 247-249 (2003)
19. Tremblay, A., J.P. Chaput: About unsuspected potential determinants of obesity. Appl Physiol Nutr Metab 33, 791-796 (2008)
20. Wams T.J.: Diethylhexylphthalate as an environmental contaminant-a review. Sci Total Environ 66, 1-16 (1987)
21. Arcadi, F.A., C. Costa, C. Imperatore, A. Marchese, A. Rapisarda,, M. Salemi, G.R. Trimarchi, G. Costa: Oral toxicity of bis(2-ethylhexyl) phthalate during pregnancy and suckling in the Long-Evans rat. Food Chem Toxicol 36, 963-970 (1998)
22. Li L.H., Jr. W.F. Jester, J.M. Orth: Effects of relatively low levels of mono-(2-ethylhexyl) phthalate on cocultured Sertoli cells and gonocytes from neonatal rats. Toxicol Appl Pharmacol 153, 258-65 (1998)
23. Grande, S.W., A.J. Andrade, C.E. Talsness, K. Grote, I. Chahoud: A dose-response study following in utero and lactational exposure to di(2-ethylhexyl)phthalate: effects on female rat reproductive development. Toxicol Sci 91, 247-254 (2006)
24. Feige, J.N., L. Gelman, D. Rossi, V. Zoete, R. Métivier, C. Tudor, S.I. Anghel, A. Grosdidier, C. Lathion, Y. Engelborghs, O. Michielin, W. Wahli, B. Desvergne: The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem 282, 19152-19166 (2007)
25. Hanlon. P.R., L.G. Ganem, Y.C. Cho, M. Yamamoto, C.R. Jefcoate: AhR-and ERK-dependent pathways function synergistically to mediate 2,3,7,8- tetrachlorodibenzo-p-dioxin suppression of peroxisome proliferator-activated receptor-gamma 1 expression and subsequent adipocyte differentiation. Toxicol Appl Pharmacol 189, 11-27 (2003)
26. Lane, M.D., Q.Q. Tang, M.S. Jiang: Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem Biophys Res Commun 266, 677-683 (1999)
27. Lefterova, M.I., M.A. Lazar: New developments in adipogenesis. Trends Endocrinol Metab 20, 107-114 (2009)
28. Tang, Q.Q., M.D. Lane: Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev 13, 2231-2241 (1999)
29. Tang, Q.Q., T.C. Otto, M.D. Lane: CCAAT/enhancer binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci USA 100, 850-855 (2003)
30. Huber, W.W., B. Grasl-Kraupp, R. Schulte-Hermann: Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit Rev Toxicol 26, 365-481 (1996)
31. Farmer, S.R.: Transcriptional control of adipocyte formation. Cell Metab 4, 263-273 (2006)
32. Gregoire, F.M., C.M. Smas, H.S. Sul: Understanding adipocyte differentiation. Physiol Rev 78, 783-809 (1998)
33. Arsenescu, V., R.I. Arsenescu, V. King, H. Swanson, L.A. Cassis: Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect 116, 761-768 (2008)
34. Miyawaki, J., K. Sakayama, H. Kato, H. Yamamoto, H. Masuno: Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J Atheroscler Thromb 14, 245-252 (2007)
35. Newbold, R.R., E. Padilla-Banks, R.J. Snyder, W.N. Jefferson: Developmental exposure to estrogenic compounds and obesity. Birth Defects Res A Clin. Mol Teratol 73, 478-480 (2005)
36. Newbold, R.R.: Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens) 9, 206-217 (2010)
37. Somm, E., V.M. Schwitzgebel, A. Toulotte, C.R. Cederroth, C. Combescure, S. Nef, M.L. Aubert, P.S. Hüppi: Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 117, 1549-1555 (2009)